Clinical trial
Single-arm, Open, Exploratory Clinical Study on the Safety and Efficacy of Piamprilimab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma
NCT05718778 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single-arm, Open, Exploratory Clinical Study on the Safety and Efficacy of Piamprilimab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma
- Lead sponsor
- Henan Cancer Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 20, 2023
- Completion date
- March 31, 2024
- Enrollment
- 31 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
soft tissue sarcoma